ATE262893T1 - Darreichungsformen zur behandlung von oralen mykosen - Google Patents

Darreichungsformen zur behandlung von oralen mykosen

Info

Publication number
ATE262893T1
ATE262893T1 AT01976055T AT01976055T ATE262893T1 AT E262893 T1 ATE262893 T1 AT E262893T1 AT 01976055 T AT01976055 T AT 01976055T AT 01976055 T AT01976055 T AT 01976055T AT E262893 T1 ATE262893 T1 AT E262893T1
Authority
AT
Austria
Prior art keywords
treatment
dosage forms
oral
mycoses
oral mycoses
Prior art date
Application number
AT01976055T
Other languages
English (en)
Inventor
Joerg Rosenberg
Gunther Berndl
Joerg Neumann
Joerg Breitenbach
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of ATE262893T1 publication Critical patent/ATE262893T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AT01976055T 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen ATE262893T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10038571A DE10038571A1 (de) 2000-08-03 2000-08-03 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
PCT/EP2001/008978 WO2002011694A2 (en) 2000-08-03 2001-08-02 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses

Publications (1)

Publication Number Publication Date
ATE262893T1 true ATE262893T1 (de) 2004-04-15

Family

ID=7651652

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976055T ATE262893T1 (de) 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen

Country Status (13)

Country Link
US (1) US20040029892A1 (de)
EP (1) EP1305010B1 (de)
JP (1) JP2004505905A (de)
CN (1) CN1274297C (de)
AT (1) ATE262893T1 (de)
AU (1) AU2001295448A1 (de)
BR (1) BR0112847A (de)
CA (1) CA2417709C (de)
DE (2) DE10038571A1 (de)
ES (1) ES2218456T3 (de)
RU (1) RU2003105812A (de)
WO (1) WO2002011694A2 (de)
ZA (1) ZA200301672B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (de) * 1999-11-12 2006-06-14 Abbott Laboratories Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2003039465A2 (en) * 2001-11-05 2003-05-15 Orahealth Corporation Treating canker sores with patches to speed healing and relieve pain
CA2489071A1 (en) * 2002-07-04 2004-01-15 Janssen Pharmaceutica N.V. Solid dispersions comprising two different polymer matrixes
DE10332160A1 (de) 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP2007517016A (ja) 2003-12-31 2007-06-28 ファイザー・プロダクツ・インク 低溶解性薬剤及びポロキサマーの固体組成物
CN1294912C (zh) * 2004-03-01 2007-01-17 上海医药工业研究院 伊曲康唑盐酸盐组合物及其冻干粉针
JP2006096728A (ja) * 2004-09-30 2006-04-13 Kobayashi Pharmaceut Co Ltd 口腔内定着型固形製剤
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
JP5410964B2 (ja) * 2006-05-23 2014-02-05 オラヘルス コーポレーション 付着性アカシアゴムを含む二層構造の口腔内付着錠
CN101108172B (zh) * 2006-07-17 2010-10-06 天津药物研究院 一种口腔粘贴片及其制备方法
GB0703998D0 (en) 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
PH12013500655A1 (en) * 2010-10-14 2016-06-29 Abbott Gmbh & Co Kg Curcuminoid solid dispersion formulation
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
US5431915A (en) * 1993-12-20 1995-07-11 Harvey; Bryce M. Frozen oral medication delivery system and method
JPH0920680A (ja) * 1995-01-24 1997-01-21 Hideyo Yamaguchi 抗真菌剤
DE19539359A1 (de) * 1995-10-23 1997-04-24 Knoll Ag Formbandkalander
EA001219B1 (ru) * 1996-05-20 2000-12-25 Жансен Фармасетика Н.В. Антигрибковые композиции с улучшенной биологической доступностью
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen

Also Published As

Publication number Publication date
DE60102590D1 (de) 2004-05-06
CA2417709A1 (en) 2002-02-14
RU2003105812A (ru) 2004-09-27
BR0112847A (pt) 2003-06-24
WO2002011694A2 (en) 2002-02-14
JP2004505905A (ja) 2004-02-26
AU2001295448A1 (en) 2002-02-18
DE60102590T2 (de) 2005-04-21
CA2417709C (en) 2010-05-11
EP1305010B1 (de) 2004-03-31
CN1444473A (zh) 2003-09-24
WO2002011694A3 (en) 2002-04-25
US20040029892A1 (en) 2004-02-12
CN1274297C (zh) 2006-09-13
DE10038571A1 (de) 2002-02-14
ES2218456T3 (es) 2004-11-16
ZA200301672B (en) 2004-03-01
EP1305010A2 (de) 2003-05-02

Similar Documents

Publication Publication Date Title
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
DK1169024T3 (da) Prægelatineret stivelse i en formulering med kontrolleret frigivelse
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
AR032293A1 (es) Estuche farmaceutico
DK0503440T3 (da) Sumatriptanholdige lægemidler
ATE450252T1 (de) Arzneimittel-mikroteilchen
ATE541562T1 (de) Ibuprofen-suspension
BG108516A (en) Pharmaceutical formulation
UY25544A1 (es) Forma de dosificación de nefazodona
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
ATE292453T1 (de) Antivirale arznei
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
AU2357202A (en) Ion-strength independent sustained release pharmaceutical formulation
EA200600603A1 (ru) Оральная система доставки лекарственного препарата
SE0001916D0 (sv) Novel formulation
HRP20020989B1 (hr) Enantiomer 1,2-aneliranog kinolina koji inhibira farnezil transferazu
MY141008A (en) Oral formulations of deoxypeganine and their uses
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
DK1499278T3 (da) Farmaceutisk doseringsform, som udviser umiddelbar frigivelse, og som omfatter polymorf tibolon
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
UY27345A1 (es) Formulación farmacéutica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties